Cargando…

Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy

The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Daniel M., Hornsby, Hailey R., Shehata, Ola M., Brown, Rebecca, Gallis, Marta, Meardon, Naomi, Newman, Thomas A.H., Plowright, Megan, Zafred, Domen, Shun-Shion, Amber S.M., Hodder, Anthony J., Bliss, Deepa, Metcalfe, Andrew, Edgar, James R., Gordon, David E., Sayers, Jon R., Nicklin, Martin J., Carroll, Miles, Collini, Paul J., Brown, Stephen, de Silva, Thushan I., Peden, Andrew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246304/
https://www.ncbi.nlm.nih.gov/pubmed/37346049
http://dx.doi.org/10.1016/j.isci.2023.107056
_version_ 1785055007627804672
author Williams, Daniel M.
Hornsby, Hailey R.
Shehata, Ola M.
Brown, Rebecca
Gallis, Marta
Meardon, Naomi
Newman, Thomas A.H.
Plowright, Megan
Zafred, Domen
Shun-Shion, Amber S.M.
Hodder, Anthony J.
Bliss, Deepa
Metcalfe, Andrew
Edgar, James R.
Gordon, David E.
Sayers, Jon R.
Nicklin, Martin J.
Carroll, Miles
Collini, Paul J.
Brown, Stephen
de Silva, Thushan I.
Peden, Andrew A.
author_facet Williams, Daniel M.
Hornsby, Hailey R.
Shehata, Ola M.
Brown, Rebecca
Gallis, Marta
Meardon, Naomi
Newman, Thomas A.H.
Plowright, Megan
Zafred, Domen
Shun-Shion, Amber S.M.
Hodder, Anthony J.
Bliss, Deepa
Metcalfe, Andrew
Edgar, James R.
Gordon, David E.
Sayers, Jon R.
Nicklin, Martin J.
Carroll, Miles
Collini, Paul J.
Brown, Stephen
de Silva, Thushan I.
Peden, Andrew A.
author_sort Williams, Daniel M.
collection PubMed
description The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged SARS-CoV-2 proteins, we found that 85% (166/196) of unvaccinated individuals with RT-PCR confirmed SARS-CoV-2 infections and 74% (31/42) of individuals infected after being vaccinated developed detectable IgG against the structural protein M, which is higher than previous estimates. Compared with N antibodies, M IgG displayed a shallower time-dependent decay and greater specificity. Sensitivity for SARS-CoV-2 seroprevalence was enhanced when N and M IgG detection was combined. These findings indicate that screening for M seroconversion may be a good approach for detecting additional vaccine breakthrough infections and highlight the potential to use HCM as a rapidly deployable method to identify the most immunogenic targets of newly emergent pathogens.
format Online
Article
Text
id pubmed-10246304
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102463042023-06-07 Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy Williams, Daniel M. Hornsby, Hailey R. Shehata, Ola M. Brown, Rebecca Gallis, Marta Meardon, Naomi Newman, Thomas A.H. Plowright, Megan Zafred, Domen Shun-Shion, Amber S.M. Hodder, Anthony J. Bliss, Deepa Metcalfe, Andrew Edgar, James R. Gordon, David E. Sayers, Jon R. Nicklin, Martin J. Carroll, Miles Collini, Paul J. Brown, Stephen de Silva, Thushan I. Peden, Andrew A. iScience Article The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged SARS-CoV-2 proteins, we found that 85% (166/196) of unvaccinated individuals with RT-PCR confirmed SARS-CoV-2 infections and 74% (31/42) of individuals infected after being vaccinated developed detectable IgG against the structural protein M, which is higher than previous estimates. Compared with N antibodies, M IgG displayed a shallower time-dependent decay and greater specificity. Sensitivity for SARS-CoV-2 seroprevalence was enhanced when N and M IgG detection was combined. These findings indicate that screening for M seroconversion may be a good approach for detecting additional vaccine breakthrough infections and highlight the potential to use HCM as a rapidly deployable method to identify the most immunogenic targets of newly emergent pathogens. Elsevier 2023-06-07 /pmc/articles/PMC10246304/ /pubmed/37346049 http://dx.doi.org/10.1016/j.isci.2023.107056 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Williams, Daniel M.
Hornsby, Hailey R.
Shehata, Ola M.
Brown, Rebecca
Gallis, Marta
Meardon, Naomi
Newman, Thomas A.H.
Plowright, Megan
Zafred, Domen
Shun-Shion, Amber S.M.
Hodder, Anthony J.
Bliss, Deepa
Metcalfe, Andrew
Edgar, James R.
Gordon, David E.
Sayers, Jon R.
Nicklin, Martin J.
Carroll, Miles
Collini, Paul J.
Brown, Stephen
de Silva, Thushan I.
Peden, Andrew A.
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
title Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
title_full Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
title_fullStr Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
title_full_unstemmed Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
title_short Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
title_sort establishing sars-cov-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246304/
https://www.ncbi.nlm.nih.gov/pubmed/37346049
http://dx.doi.org/10.1016/j.isci.2023.107056
work_keys_str_mv AT williamsdanielm establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT hornsbyhaileyr establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT shehataolam establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT brownrebecca establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT gallismarta establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT meardonnaomi establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT newmanthomasah establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT plowrightmegan establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT zafreddomen establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT shunshionambersm establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT hodderanthonyj establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT blissdeepa establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT metcalfeandrew establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT edgarjamesr establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT gordondavide establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT sayersjonr establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT nicklinmartinj establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT carrollmiles establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT collinipaulj establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT brownstephen establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT desilvathushani establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy
AT pedenandrewa establishingsarscov2membraneproteinspecificantibodiesasavaluableserologicaltargetviahighcontentmicroscopy